mobi 1901 account 33333 jznz mm

16
AUTOMATED DIABETES DIARY Visualizing data from wellness trackers and medical devices for personalized diabetes treatment

Upload: upload123

Post on 19-Jan-2021

8 views

Category:

Investor Relations


0 download

DESCRIPTION

Jznz msz

TRANSCRIPT

Page 1: Mobi 1901 account 33333 jznz mM

AUTOMATED DIABETES DIARY

Visualizing data fromwellness trackers and medical devicesfor personalized diabetes treatment

Page 2: Mobi 1901 account 33333 jznz mM

TRACKAND

LEARN

Page 3: Mobi 1901 account 33333 jznz mM

Diabetes treatment costs in 2013: $ 548 B

$

†<60y

Page 4: Mobi 1901 account 33333 jznz mM

> 1 000 apps, only 1.2 % penetration

“Apps rely on manual input of data.”“No interoperability with glucometers, health & fitness apps.”

Page 5: Mobi 1901 account 33333 jznz mM

Glucose readings from meter & pumpActivity, nutrition info from trackersAnnotations

Support for multiple metersPatient owns the data

Competition

Page 6: Mobi 1901 account 33333 jznz mM

PHR

Meals ActivityStress

Page 7: Mobi 1901 account 33333 jznz mM

Business model: Phase 1

Go-to-market via• Diabetes organizations• Healthcare organizations• App stores

People with diabetes pay 79 € / y

Page 8: Mobi 1901 account 33333 jznz mM

Revenue Streams: Phase 2Healthcare organizations pay for service and data– Patient empowerment saves cost– Personalized healthcare improves results– Legal obligations

Pharma companies pay for data– Valuable for product development

Insurance companies pay for data– Improved risk calculation– Payer role, want to improve treatment

Device manufacturers pay for integration– Better value for users

Page 9: Mobi 1901 account 33333 jznz mM

H2/13 2014 2015 2016 2017 2018 2019

Personnel 3 3 3 5 8 12 16 20 30 60 75 90

Users 2 2 500 2.5 K 15 K 40 K 70 K 250 K 600 K 1.2 M 2.5 M 6 M

Revenue 0 0 675 K 1.5 M 11.4 M 92 M 484 M

Cost 0 195 K 950 K 1.4 M 16.1 M 52 M 120 M

Ebitda 0 -195 K -275 K 100 K -4.7 M 40 M 364 M

First users,

soft launch

Launch: F

inland

Launch: E

urope

Medical D

evice Cert.

Financials and Roadmap

FDA ap

proval

Launch

: USA

& Canad

a

Page 10: Mobi 1901 account 33333 jznz mM

Pirjo Ilanne-Parikka, MD, Finnish Diabetes Assoc.Jorma Lahtela, MD, UTA / UKU / TAYSPäivi Hannula, MD, PSHPAntti Virkamäki, MD, CMO, MendorAtte Vadén, MD, Koskiklinikka / MediverkkoJyrki Lähde, MD, Terveystalo

Type 1 diabetic (14 y), software pro (15 y)Startup experience (14 y)

Type 1 diabetic (4 y), software pro (15 y)Military software, visualisation

Healthcare PR, marketing (6 y)Protomo startup coaching

Mikael

Timo

Assi

Advisors

Page 11: Mobi 1901 account 33333 jznz mM
Page 12: Mobi 1901 account 33333 jznz mM
Page 13: Mobi 1901 account 33333 jznz mM

Trade Sale Opportunities

Page 14: Mobi 1901 account 33333 jznz mM

Investment Opportunity

Looking for 100 000 €, to– finalize product, start user trials in Q2 2014– launch in Finland on World Diabetes Day 14.11.2014– prepare for next round in Q1 2015, for medical device

certification and international growth

Also looking for advice and connections

Page 15: Mobi 1901 account 33333 jznz mM

…making sense of diabetes trends

Mikael Rinnetmä[email protected]

+358 50 3855511linkedin.com/in/mikaelrinnetmaki

twitter.com/mrinnetmaki

www.sensotrend.com/linkedin.com/company/sensotrendtwitter.com/sensotrendfacebook.com/sensotrend gust.com/c/sensotrend

Page 16: Mobi 1901 account 33333 jznz mM

Power Pitch

• Sensotrend makes life with diabetes easierwith an automated diabetes diaryutilizing data from wellness trackers.

• Our team consists of diabetics and their relatives, and we’ve got 6 top name diabetes doctors as advisors.

• We have a scalable business model with multiple revenue streams, and a first mover advantage on a globally growing market, driven by changes in legislation.